Venaxis Inc news

   Watch this stock
Showing stories 1 - 10 of about 28   

Articles published

APPY 1.97 +0.06 (3.14%)
price chart
Venaxis to Present at ICV Company Outreach Summit
CASTLE ROCK, Colo., July 1, 2014 /PRNewswire/ -- Venaxis, Inc. (NASDAQ:APPY) , an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1� Test, a rapid, multiple biomarker-based assay for ...
Related articles »  
Diagnostic Substances: Venaxis Inc (NASDAQ:APPY), Meridian Bioscience ...
On 1 july 2014 Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1� Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for ...
Venaxis Reports on Recent FDA Submission Activities
Venaxis, Inc. is an in vitro diagnostic company focused on the clinical development and commercialization of its CE Marked APPY1 Test, the Company's rapid, multi-analyte assay for appendicitis.
Related articles »  
Stocks in the Spotlight: Petroquest Energy Inc (PQ), Venaxis Inc (NASDAQ:APPY ...
Venaxis Inc (NASDAQ:APPY) announced it will participate in the third annual ICV Company Outreach Summit, being held July 9-10, 2014, in Montauk, New York.
Related articles »  
Microcap Volatile Stocks: LiveDeal Inc (NASDAQ:LIVE), Venaxis Inc (NASDAQ ...
On June 24, 2014, LiveDeal Inc. (NASDAQ:LIVE) (�LiveDeal� or the �Company�), a publicly traded company that operates livedeal.
Stocks in a bear Hug - Miller Energy Resources Inc (NYSE:MILL), Venaxis ...
Birmingham, West Midlands - (TechSonian) - 07/17/2014 �Elitestockpicks.com is a Stock newsletter website that provides free daily alerts on hot Moving stocks.
Healthcare Volatile Stocks: Infinity Pharmaceuticals Inc. (NASDAQ:INFI ...
Venaxis Inc. (NASDAQ:APPY) an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1� Test, a rapid, multi-analyte assay for aiding in identifying children, adolescent and young adult patients that ...
Related articles »  
Morning Buzz - NII Holdings, (NASDAQ:NIHD), American Apparel, (NYSEMKT ...
Venaxis, (NASDAQ:APPY), announced it has participated in the third annual ICV Company Outreach Summit, held July 9-10, 2014, in Montauk, New York.
Related articles »  
Declaration on Hit List: American Superconductor (NASDAQ:AMSC), Barrick ...
Venaxis Inc (NASDAQ:APPY) [Trend Analysis] issues an update on current activities concerning its FDA submission for the APPY1 Test that was filed in March 2014.
Unusual 11 Mid-Day Movers 07/16: (ZIPR) (NLST) (ICAD) Higher; (ININ) (BIOA ...
Venaxis, Inc. (Nasdaq: APPY) 7.2% LOWER; updated on recent activities concerning its U. S. Food and Drug Administration (FDA) submission for the APPY1 Test that was filed in March 2014.